Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ · Healthcare
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $1B
- P/E ratio
- —
- EPS
- —
- Volume
- 718,158
- 52-week high
- —
- 52-week low
- —
- Open
- $11.44
- Day high
- $11.62
- Day low
- $11.29
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | — | -$162.45M | -$1.87 |
| 2024 | — | -$129.47M | -$2.20 |
| 2023 | — | -$96.66M | -$2.14 |
| 2022 | — | -$104.79M | -$2.62 |
| 2021 | — | -$71.1M | -$1.80 |
About Olema Pharmaceuticals, Inc.
Olema Pharmaceuticals, Inc., a biopharmaceutical enterprise in the clinical development stage, is dedicated to discovering, advancing, and commercializing therapeutic solutions for women's oncology. Headquartered in San Francisco, California, the company was established in 2006 and rebranded from CombiThera, Inc. in March 2009. Its most promising investigational compound, OP-1250, an estrogen receptor (ER) antagonist and selective ER degrader, is presently undergoing Phase 1/2 clinical evaluations. This drug candidate is being assessed for its efficacy in managing recurrent, locally advanced, or metastatic breast cancer that expresses estrogen receptors but is negative for human epidermal growth factor receptor 2.
- CEO
- Sean Bohen
- Employees
- 137
- Country
- US
- IPO date
- Nov 19, 2020
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is Olema Pharmaceuticals, Inc.'s stock price today?
- OLMA is trading at $11.35 as of Jul 20, 2026.
- What is Olema Pharmaceuticals, Inc.'s market cap?
- Olema Pharmaceuticals, Inc. (OLMA) has a market capitalization of $1B.
- Does Olema Pharmaceuticals, Inc. pay a dividend?
- Olema Pharmaceuticals, Inc. did not pay a dividend in its most recent reported fiscal year.
- What sector is Olema Pharmaceuticals, Inc. in?
- Olema Pharmaceuticals, Inc. operates in the Healthcare sector.